Géza Berecki1, Alexander Bryson1, Jan Terhag1, Snezana Maljevic1, Elena V Gazina1, Sean L Hill2, Steven Petrou1,3. 1. Ion Channels and Disease Group, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. 2. Blue Brain Project, Swiss Federal Institute of Technology in Lausanne, Geneva, Switzerland. 3. Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
Abstract
OBJECTIVE: To elucidate the biophysical basis underlying the distinct and severe clinical presentation in patients with the recurrent missense SCN1A variant, p.Thr226Met. Patients with this variant show a well-defined genotype-phenotype correlation and present with developmental and early infantile epileptic encephalopathy that is far more severe than typical SCN1A Dravet syndrome. METHODS: Whole cell patch clamp and dynamic action potential clamp were used to study T226M Nav 1.1 channels expressed in mammalian cells. Computational modeling was used to explore the neuronal scale mechanisms that account for altered action potential firing. RESULTS: T226M channels exhibited hyperpolarizing shifts of the activation and inactivation curves and enhanced fast inactivation. Dynamic action potential clamp hybrid simulation showed that model neurons containing T226M conductance displayed a left shift in rheobase relative to control. At current stimulation levels that produced repetitive action potential firing in control model neurons, depolarization block and cessation of action potential firing occurred in T226M model neurons. Fully computationally simulated neuron models recapitulated the findings from dynamic action potential clamp and showed that heterozygous T226M models were also more susceptible to depolarization block. INTERPRETATION: From a biophysical perspective, the T226M mutation produces gain of function. Somewhat paradoxically, our data suggest that this gain of function would cause interneurons to more readily develop depolarization block. This "functional dominant negative" interaction would produce a more profound disinhibition than seen with haploinsufficiency that is typical of Dravet syndrome and could readily explain the more severe phenotype of patients with T226M mutation. Ann Neurol 2019;85:514-525.
OBJECTIVE: To elucidate the biophysical basis underlying the distinct and severe clinical presentation in patients with the recurrent missense SCN1A variant, p.Thr226Met. Patients with this variant show a well-defined genotype-phenotype correlation and present with developmental and early infantile epilepticencephalopathy that is far more severe than typical SCN1ADravet syndrome. METHODS: Whole cell patch clamp and dynamic action potential clamp were used to study T226MNav 1.1 channels expressed in mammalian cells. Computational modeling was used to explore the neuronal scale mechanisms that account for altered action potential firing. RESULTS:T226M channels exhibited hyperpolarizing shifts of the activation and inactivation curves and enhanced fast inactivation. Dynamic action potential clamp hybrid simulation showed that model neurons containing T226M conductance displayed a left shift in rheobase relative to control. At current stimulation levels that produced repetitive action potential firing in control model neurons, depolarization block and cessation of action potential firing occurred in T226M model neurons. Fully computationally simulated neuron models recapitulated the findings from dynamic action potential clamp and showed that heterozygous T226M models were also more susceptible to depolarization block. INTERPRETATION: From a biophysical perspective, the T226M mutation produces gain of function. Somewhat paradoxically, our data suggest that this gain of function would cause interneurons to more readily develop depolarization block. This "functional dominant negative" interaction would produce a more profound disinhibition than seen with haploinsufficiency that is typical of Dravet syndrome and could readily explain the more severe phenotype of patients with T226M mutation. Ann Neurol 2019;85:514-525.
Authors: Madeline Angus; Colin H Peters; Damon Poburko; Elise Brimble; Emily M Spelbrink; Peter C Ruben Journal: J Neurophysiol Date: 2019-09-18 Impact factor: 2.714
Authors: Eric R Wengert; Raquel M Miralles; Kyle C A Wedgwood; Pravin K Wagley; Samantha M Strohm; Payal S Panchal; Abrar Majidi Idrissi; Ian C Wenker; Jeremy A Thompson; Ronald P Gaykema; Manoj K Patel Journal: J Neurosci Date: 2021-09-20 Impact factor: 6.167
Authors: Andreas Brunklaus; Eduardo Pérez-Palma; Ismael Ghanty; Ji Xinge; Eva Brilstra; Berten Ceulemans; Nicole Chemaly; Iris de Lange; Christel Depienne; Renzo Guerrini; Davide Mei; Rikke S Møller; Rima Nabbout; Brigid M Regan; Amy L Schneider; Ingrid E Scheffer; An-Sofie Schoonjans; Joseph D Symonds; Sarah Weckhuysen; Michael W Kattan; Sameer M Zuberi; Dennis Lal Journal: Neurology Date: 2022-01-24 Impact factor: 11.800